Compare NVX & QSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NVX | QSI |
|---|---|---|
| Founded | 2012 | 2013 |
| Country | Australia | United States |
| Employees | 192 | 145 |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Miscellaneous | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 144.3M | 161.8M |
| IPO Year | N/A | N/A |
| Metric | NVX | QSI |
|---|---|---|
| Price | $0.70 | $0.74 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $1.00 |
| AVG Volume (30 Days) | 378.9K | ★ 2.8M |
| Earning Date | 04-23-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $3,904.19 | N/A |
| Revenue Next Year | $91.72 | $618.07 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.61 | $0.69 |
| 52 Week High | $3.86 | $3.10 |
| Indicator | NVX | QSI |
|---|---|---|
| Relative Strength Index (RSI) | 45.33 | 37.05 |
| Support Level | $0.63 | N/A |
| Resistance Level | $0.81 | $1.11 |
| Average True Range (ATR) | 0.05 | 0.05 |
| MACD | 0.01 | -0.00 |
| Stochastic Oscillator | 50.69 | 24.91 |
NOVONIX Ltd is a battery technology company developing and scaling materials and equipment critical to the lithium-ion battery supply chain. The company has three operating segments: Battery Materials: It develops and manufactures battery anode materials, ii) Battery Technology: It develops and manufactures battery cell testing equipment, performs consulting services and carries out research and development in battery development, and Graphite Exploration: It manages the maintenance and future development of Mount Dromedary natural graphite deposit. The majority of the company's revenue is derived from the Battery Technology segment. Geographically, the maximum revenue is derived from North America, followed by Asia, and Europe.
Quantum-Si Inc is a life sciences company focused on proteomics research and analytical technologies. It develops single-molecule detection platforms designed to enable next-generation protein sequencing (NGPS) and large-scale protein analysis. Its technology supports massively parallel sequencing of proteins and can also be applied to the study of nucleic acids, providing tools for researchers and clinical applications in molecular analysis. The company's revenue is derived from sales of products and services.